The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
Abstract
The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly suggest the potential adoption of NO donor-based therapy in clinical practice, and this has been supported by several clinical studies in the past decade. In this review, we first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy. Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity. In addition, we briefly describe inducible NO synthase gene therapy and nanotechnology, which have recently entered the field of NO donor therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Nitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Nitric oxide donors: chemical activities and biological applications
Wang, P. G., Xian, M., Tang, X., Wu, X., Wen, Z., Cai, T., & Janczuk, A. J. (2002) · Chemical Reviews · doi:10.1021/cr000040l · Cited by 1,337
The role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
The chemical biology of nitric oxide: Implications in cellular signaling
Thomas, D. D., Ridnour, L. A., Isenberg, J. S., Flores-Santana, W., Switzer, C. H., Donzelli, S., Hussain, P., Vecoli, C., Paolocci, N., Ambs, S., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.020 · Cited by 975
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704
Geller, D. A., Nussler, A. K., Di Silvio, M., Lowenstein, C. J., Shapiro, R. A., Wang, S. C., Simmons, R. L., & Billiar, T. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.522 · Cited by 665
Recent developments in nitric oxide donor drugs
Miller, M. R., & Megson, I. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707224 · Cited by 628
Malinski, T., Bailey, F., Zhang, Z. G., & Chopp, M. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.48 · Cited by 625
Virus treatment questioned after gene therapy death
Lehrman, S. (1999) · Nature · doi:10.1038/43977 · Cited by 576
Role of nitric oxide in carcinogenesis and tumour progression
Lala, P. K., & Chakraborty, C. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00256-4 · Cited by 570
Signal transduction mechanisms involving nitric oxide
Ignarro, L. J. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90618-f · Cited by 525
Nitric Oxide: Cytotoxicity versus Cytoprotection— How, Why, When, and Where?
Kröncke, K.-D., Fehsel, K., & Kolb-Bachofen, V. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0118 · Cited by 510
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
Mocellin, S., Bronte, V., & Nitti, D. (2007) · Medicinal Research Reviews · doi:10.1002/med.20092 · Cited by 478
Nitric oxide release: Part I. Macromolecular scaffolds
Riccio, D. A., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15272j · Cited by 475
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Hrabie, J. A., & Keefer, L. K. (2002) · Chemical Reviews · doi:10.1021/cr000028t · Cited by 466
Biological nitric oxide signalling: chemistry and terminology
Heinrich, T. A., da Silva, R. S., Miranda, K. M., Switzer, C. H., Wink, D. A., & Fukuto, J. M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12217 · Cited by 285
Riganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
S-nitrosylation: a potential new paradigm in signal transduction
Martínez-Ruiz, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.013 · Cited by 253
NO, nitrotyrosine, and cyclic GMP in signal transduction.
Hanafy, K. A., Krumenacker, J. S., & Murad, F. (2001) · PubMed · Cited by 236
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation
Chen, Z., Foster, M. W., Zhang, J., Mao, L., Rockman, H. A., Kawamoto, T., Kitagawa, K., Nakayama, K. I., Hess, D. T., & Stamler, J. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503723102 · Cited by 231
Nitric oxide donors: Novel cancer therapeutics (Review)
Huerta (1992) · international Journal of Oncology · doi:10.3892/ijo_00000079 · Cited by 222
Exercise, Vascular Wall and Cardiovascular Diseases: An Update (Part 1)
Leung, F. P., Yung, L. M., Laher, I., Yao, X., Chen, Z. Y., & Huang, Y. (2008) · Sports Medicine · doi:10.2165/00007256-200838120-00005 · Cited by 219
Nitric Oxide:Biochemistry, Pathophysiology, and Detection
Kiechle, F. L., & Malinski, T. (1993) · American Journal of Clinical Pathology · doi:10.1093/ajcp/100.5.567 · Cited by 219
Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies
Singh, S., & Gupta, A. K. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1654-4 · Cited by 212
Yasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
DT-diaphorase: a target for new anticancer drugs
Danson, S., Ward, T. H., Butler, J., & Ranson, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.01.002 · Cited by 187
Biological activity of ruthenium nitrosyl complexes
Tfouni, E., Truzzi, D. R., Tavares, A., Gomes, A. J., Figueiredo, L. E., & Franco, D. W. (2012) · Nitric Oxide · doi:10.1016/j.niox.2011.11.005 · Cited by 186
Chung, M., Liu, H., Lin, K., Chia, W., & Sung, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504444 · Cited by 185
Nitric Oxide and Cell Signaling Pathways in Mitochondrial-Dependent Apoptosis
Boyd, C. S., & Cadenas, E. (2002) · Biological Chemistry · doi:10.1515/bc.2002.045 · Cited by 182
Keefer, L. K. (2011) · ACS Chemical Biology · doi:10.1021/cb200274r · Cited by 182
Nitric oxide in cancer metastasis
Cheng, H., Wang, L., Mollica, M., Re, A. T., Wu, S., & Zuo, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.014 · Cited by 182
Nitrates and no release: contemporary aspects in biological and medicinal chemistry
Thatcher, G. R. J., Nicolescu, A. C., Bennett, B. M., & Toader, V. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.013 · Cited by 171
Yasuda, H., Yamaya, M., Nakayama, K., Sasaki, T., Ebihara, S., Kanda, A., Asada, M., Inoue, D., Suzuki, T., Okazaki, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0436 · Cited by 170
A platform for nitric oxide delivery
Kim, J., Saravanakumar, G., Choi, H. W., Park, D., & Kim, W. J. (2014) · J. Mater. Chem. B · doi:10.1039/c3tb21259a · Cited by 166
Delivering nitric oxide with nanoparticles
Quinn, J. F., Whittaker, M. R., & Davis, T. P. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.007 · Cited by 165
Huerta-Yepez, S., Vega, M., Jazirehi, A., Garban, H., Hongo, F., Cheng, G., & Bonavida, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207655 · Cited by 165
Shami, P. J., Saavedra, J. E., Wang, L. Y., Bonifant, C. L., Diwan, B. A., Singh, S. V., Gu, Y., Fox, S. D., Buzard, G. S., Citro, M. L., et al. (2003) · PubMed · Cited by 162
Hulsman, N., Medema, J. P., Bos, C. L., Jongejan, A., Leurs, R., Smit, M. J., de Esch, I. J. P., Richel, D. J., & Wijtmans, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061371e · Cited by 157
Therapeutic potential of nitric oxide in cancer
Bonavida, B., KHINECHE, S., Huerta‐Yépez, S., & Garbán, H. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.003 · Cited by 151
Pipili‐Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., & Maragoudakis, M. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16670.x · Cited by 151
Nitric-oxide-donating NSAIDs as agents for cancer prevention
Rigas, B., & Kashfi, K. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.004 · Cited by 147
Bonavida, B., & Baritaki, S. (2010) · Nitric Oxide · doi:10.1016/j.niox.2010.10.001 · Cited by 144
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
Schaer, D., Hirschhorn-Cymerman, D., & Wolchok, J. D. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-7 · Cited by 134
Saavedra, J. E., Shami, P. J., Wang, L. Y., Davies, K. M., Booth, M. N., Citro, M. L., & Keefer, L. K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903850 · Cited by 132
Chattopadhyay, M., Kodela, R., Olson, K. R., & Kashfi, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.051 · Cited by 127
Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome
Glockzin, S., von Knethen, A., Scheffner, M., & Brüne, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19581 · Cited by 127
Shami, P. J., Saavedra, J. E., Bonifant, C. L., Chu, J., Udupi, V., Malaviya, S., Carr, B. I., Kar, S., Wang, M., Jia, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060022h · Cited by 107
Ning, S., Bednarski, M. D., Oronsky, B. T., Scicinski, J. J., Saul, G., & Knox, S. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2303 · Cited by 104
Chen, L., Zhang, Y., Kong, X., Lan, E., Huang, Z., Peng, S., Kaufman, D. L., & Tian, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800167u · Cited by 101
Self-citationBoo, S. D., Kopecka, J., Brusa, D., Gazzano, E., Matera, L., Ghigo, D., Bosìa, A., & Riganti, C. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-108 · Cited by 101
Duan, W., Li, J., Inks, E. S., Chou, C. J., Jia, Y., Chu, X., Li, X., Xu, W., & Zhang, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00317 · Cited by 98
Self-citationSaavedra, J. E., Srinivasan, A., Bonifant, C. L., Chu, J., Shanklin, A. P., Flippen-Anderson, J. L., Rice, W. G., Turpin, J. A., Davies, K. M., & Keefer, L. K. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo0016529 · Cited by 97
Biological signaling by small inorganic molecules
Basudhar, D., Ridnour, L. A., Cheng, R. Y. S., Kesarwala, A. H., Heinecke, J. L., & Wink, D. A. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.06.001 · Cited by 97
Saavedra, J. E., Srinivasan, A., Buzard, G. S., Davies, K. M., Waterhouse, D. J., Inami, K., Wilde, T. C., Citro, M. L., Cuellar, M. E., Deschamps, J. R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050700k · Cited by 92
Reid, T. R., Oronsky, B. T., Scicinski, J. J., Scribner, C. L., Knox, S. J., Ning, S., Peehl, D. M., Korn, R. L., Stirn, M., Carter, C. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00089-3 · Cited by 92
Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy
Tranoy‐Opalinski, I., Fernandes, A. E., Thomas, M., GESSON, J. ‐., & Papot, S. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785133065 · Cited by 90
Li, C., Robles, A. I., Hanigan, C. L., Hofseth, L. J., Trudel, L. J., Harris, C. C., & Wogan, G. N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1880 · Cited by 81
Chegaev, K. Y., Riganti, C., Lazzarato, L., Rolando, B., Guglielmo, S., Campia, I., Fruttero, R., Bosìa, A., & Gasco, A. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100302t · Cited by 79
The role of nitric oxide chemistry in cancer treatment.
Wink, D. A., Vodovotz, Y., Cook, J. A., et al. (1998) · PubMed · Cited by 78
Han, C., Huang, Z., Zheng, C., Wan, L., Zhang, L., Peng, S., Ding, K., Ji, H., Tian, J., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400463q · Cited by 76
Self-citationSynthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates
Cai, T., Tang, X., Nagorski, J., Brauschweiger, P. G., & Wang, P. G. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.003 · Cited by 75
Maksimovic-Ivanic, D., Mijatovic, S., Harhaji, L., Miljkovic, D., Dabideen, D., Fan Cheng, K., Mangano, K., Malaponte, G., Al-Abed, Y., Libra, M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2037 · Cited by 74
Mitochondrial-Targeting Nitrooxy-doxorubicin: A New Approach To Overcome Drug Resistance
Riganti, C., Rolando, B., Kopecka, J., Campia, I., Chegaev, K. Y., Lazzarato, L., Federico, A., Fruttero, R., & Ghigo, D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300311b · Cited by 74
Ai, Y., Kang, F., Huang, Z., Xue, X., Lai, Y., Peng, S., Tian, J., & Zhang, Y. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019302 · Cited by 71
Self-citationNitric Oxide-mediated Vasorelaxation
Ignarro, L. J. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646177 · Cited by 70
Ling, Y., Ye, X., Zhang, Z., Zhang, Y., Lai, Y., Ji, H., Peng, S., & Tian, J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014814 · Cited by 69
Self-citationNitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives
Seabra, A. B., de Lima, R., & Calderón, M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150108122918 · Cited by 68
Kashfi, K., Chattopadhyay, M., & Kodela, R. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.012 · Cited by 64
INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug
Sharma, K., Iyer-Bierhoff, A., Sengupta, K., & Chakrapani, H. (2013) · Organic Letters · doi:10.1021/ol400884v · Cited by 64
Huang, B., Desai, A. M., Tang, S., Thomas, T. P., & Baker, J. R. (2010) · Organic Letters · doi:10.1021/ol1002626 · Cited by 63
Zhao, J., Gou, S., Sun, Y., Fang, L., & Wang, Z. (2012) · Inorganic Chemistry · doi:10.1021/ic301374z · Cited by 63
Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donors
Wu, X., Tang, X., Xian, M., & Wang, P. G. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)00614-1 · Cited by 62
Fang, L., Wang, M., Gou, S., Liu, X., Zhang, H., & Cao, F. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401634d · Cited by 61
Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
Sukhatme, V. V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.568 · Cited by 60
Fu, J., Liu, L., Huang, Z., Lai, Y., Ji, H., Peng, S., Tian, J., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400393u · Cited by 60
Self-citationNitroreductase-activated nitric oxide (NO) prodrugs
Sharma, K., Sengupta, K., & Chakrapani, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.066 · Cited by 57
RRx-001, A novel dinitroazetidine radiosensitizer
Oronsky, B. T., Scicinski, J. J., Ning, S., Peehl, D. M., Oronsky, A. L., Cabrales, P., Bednarski, M. D., & Knox, S. J. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0326-y · Cited by 56
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein
Fruttero, R., Crosetti, M., Chegaev, K. Y., Guglielmo, S., Gasco, A., Berardi, F., Niso, M., Perrone, R., Panaro, M. A., & Colabufo, N. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100066y · Cited by 55
Arrieta, O. G., Blake, M., de la Mata-Moya, M. D., Corona-Cruz, J. F., Turcott, J. G., Orta, D., Alexander-Alatorre, J., & Gallardo‐Rincón, D. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.01.021 · Cited by 54
Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity
Zhao, H., Ning, S., Scicinski, J. J., Oronsky, B. T., Knox, S. J., & Peehl, D. M. (2015) · Oncotarget · doi:10.18632/oncotarget.6526 · Cited by 53
Scicinski, J. J., Oronsky, B. T., Taylor, M., Luo, G., Musick, T. J., Marini, J., Adams, C. M., & Fitch, W. L. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046755 · Cited by 50
Lai, Y., Shen, L., Zhang, Z., Liu, W., Zhang, Y., Ji, H., & Tian, J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.070 · Cited by 49
Self-citationWeyerbrock, A., Walbridge, S., Pluta, R. M., Saavedra, J. E., Keefer, L. K., & Oldfield, E. H. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.4.0728 · Cited by 45
Ling, Y., Ye, X., Ji, H., Zhang, Y., Lai, Y., Peng, S., & Tian, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.077 · Cited by 43
Self-citationLi, X., Wang, X., Xu, C., Huang, J., Wang, C., Wang, X., He, L., & Ling, Y. (2015) · MedChemComm · doi:10.1039/c5md00158g · Cited by 42
Tari (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.925 · Cited by 42
Stewart, G. D., Nanda, J., Brown, D. J., Riddick, A. C. P., Ross, J. A., & Habib, F. K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23934 · Cited by 41
Valdez, C. A., Saavedra, J. E., Showalter, B. M., Davies, K. M., Wilde, T. C., Citro, M. L., Barchi, J. J., Deschamps, J. R., Parrish, D. A., El-Gayar, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000482 · Cited by 41
Dingemans, A. C., Groen, H. J. M., Herder, G. J. M., Stigt, J. A., Smit, E. F., Bahce, I., Burgers, J. A., van den Borne, B. E. E. M., Biesma, B., Vincent, A. D., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv370 · Cited by 41
Nitric Oxide Donor‐Based Platinum Complexes as Potential Anticancer Agents
Zhao, J., Gou, S.-H., Sun, Y., Yin, R., & Wang, Z. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201605 · Cited by 41
Synthesis of peptide-diazeniumdiolate conjugates: towards enzyme activated antitumor agents
Tang, X., Xian, M., Trikha, M., Honn, K. V., & Wang, P. G. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)00263-5 · Cited by 41
Ning, S., Bednarski, M. D., Oronsky, B. T., Scicinski, J. J., & Knox, S. J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.032 · Cited by 40
Allimuthu, D., Ravikumar, G., & Chakrapani, H. (2014) · Organic Letters · doi:10.1021/ol5010643 · Cited by 39
Gu, X., Huang, Z., Ren, Z., Tang, X., Xue, R., Luo, X., Peng, S., Peng, H., Lü, B., Tian, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01075 · Cited by 39
Self-citationMaciag, A. E., Holland, R. J., Kim, Y., Kumari, V., Luthers, C. E., Sehareen, W. S., Biswas, D., Morris, N. L., Ji, X., Anderson, L. M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401550d · Cited by 38
Reinmuth, N., Meyer, A. A., Hartwigsen, D., Schaeper, C., Huebner, G., Skock-Lober, R., Bier, A., Gerecke, U., Held, C. P., & Reck, M. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.01.001 · Cited by 37
Li, D., Wang, L., Cai, H., Zhang, Y., & Xu, J. (2012) · Molecules · doi:10.3390/molecules17067556 · Cited by 35
Self-citationVannini, F., MacKessack-Leitch, A. C., Eschbach, E. K., Chattopadhyay, M., Kodela, R., & Kashfi, K. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.023 · Cited by 33
Sialated Diazeniumdiolate: A New Sialidase-Activated Nitric Oxide Donor
Cai, T., Lu, D., Landerholm, M., & Wang, P. G. (2004) · Organic Letters · doi:10.1021/ol048397p · Cited by 33
Chakrapani, H., Wilde, T. C., Citro, M. L., Goodblatt, M. M., Keefer, L. K., & Saavedra, J. E. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.035 · Cited by 32
Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells
Mojić, M., Mijatović, S., Maksimović‐Ivanić, D., Miljković, D. M., Stošić‐Grujičić, S., Stankovic, M. M., Mangano, K., Travali, S., Donia, M., Fagone, P., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077842 · Cited by 31
The Implications of Hyponitroxia in Cancer
Oronsky, B. T., Fanger, G. R., Oronsky, N. C., Knox, S. J., & Scicinski, J. J. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.02.001 · Cited by 30
Pestana, C. R., Phelippin, D. P. S., Polizello, A. C. M., Dorta, D. J., Uyemura, S. A., dos Santos, A. C., Doro, F. G., Rodrigues, F. P., Tfouni, E., & Curti, C. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.10.001 · Cited by 30
Somasundaram, V., Nadhan, R., Hemalatha, S. K., Sengodan, S. K., & Srinivas, P. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.004 · Cited by 29
Xu, S., Wang, G., Lin, Y., Zhang, Y., Pei, L., Yao, H., Hu, M. Y., Qiu, Y., Huang, Z., Zhang, Y., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.068 · Cited by 29
Self-citationYe, S., Yang, W., Wang, Y., Ou, W., Ma, Q., Yu, C., Ren, J., Zhong, G., Shi, H., Yuan, Z., et al. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1171 · Cited by 28
Zhou, H., Huang, L., Sun, Y., & Rigas, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.006 · Cited by 27
Wang, T., Zhang, Y., Kong, X., Lai, Y., Ji, H., Chen, Y., & Peng, S. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200800014 · Cited by 26
Self-citationSodium nitroprusside (SNP) sensitizes human gastric cancer cells to TRAIL-induced apoptosis
Yang, L.-Q., Lan, C., Yu, F., Zhang, Y., Wang, J., Guo, J., Wan, S., Yang, S., Wang, R., & Fang, D.-C. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.021 · Cited by 26
Self-citationMijatović, S., Maksimović‐Ivanić, D., Mojić, M., Malaponte, G., Libra, M., Cardile, V., Miljković, D. M., Harhaji-Trajkovic, L. M., Dabideen, D. R., Cheng, K. F., et al. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.004 · Cited by 26
Konter, J., Abuo‐Rahma, G. E. A., El-Emam, A. A.-R., & Lehmann, J. (2006) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200600662 · Cited by 25
Chaudhary, S. C., Singh, T., Kapur, P., Weng, Z., Arumugam, A., Elmets, C. A., Kopelovich, L., & Athar, M. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.009 · Cited by 25
Bonavida, B., Baritaki, S., Huerta‐Yépez, S., Vega, M. I., Jazirehi, A. R., & Berenson, J. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_24 · Cited by 25
Fang, L., Feng, M., Chen, F., Liu, X., Shen, H., Zhao, J., & Gou, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.066 · Cited by 25
Huang, Z., Fu, J., Liu, L., Sun, Y., Lai, Y., Ji, H., Knaus, E. E., Tian, J., & Zhang, Y. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25252j · Cited by 24
Self-citationA Glycosylated Nitric Oxide Donor, β‐Gal‐NONOate, and its Site‐specific Antitumor Activity
Chen, C., Shi, Y., Li, S., Qi, Q., Gu, L., Song, J., & Wang, P. G. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200500262 · Cited by 23
Zou, Z., Lan, X., Qian, H., Huang, W., & Li, Y. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.077 · Cited by 22
Díez, I., Calatayud, S., Hernández, C., Quintana, E., O'Connor, J., Esplugues, J. V., & Barrachina, M. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00654.x · Cited by 20
Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy
McCarthy, H. O., Zholobenko, A., Wang, Y., Canine, B., Robson, T., Hirst, D. G., & Hatefi, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.051 · Cited by 20
He, L. Q., Liu, J. L., Yin, D. K., Zhang, Y. H., & Wang, T. (2010) · Chinese Chemical Letters · doi:10.1016/j.cclet.2009.11.033 · Cited by 19
Self-citationTang, X., Gu, X., Ai, H., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.065 · Cited by 19
Xue, R., Wu, J., Luo, X., Gong, Y. M., Huang, Y., Shen, X., Zhang, H., Zhang, Y., & Huang, Z. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b02222 · Cited by 18
Self-citationNortcliffe, A., Fleming, I. N., Botting, N. P., & O’Hagan, D. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.09.004 · Cited by 16
Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules
Pauwels, B., Boydens, C., Daele, L. V., & de Voorde, J. V. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12511 · Cited by 16
Cabrales, P., Scicinski, J. J., Reid, T. R., Kuypers, F. A., Larkin, S. K., Fens, M. H. A. M., Oronsky, A. L., & Oronsky, B. T. (2016) · Medical Oncology · doi:10.1007/s12032-016-0775-3 · Cited by 15
Nath, N., Chattopadhyay, M., Rodes, D. B., Nazarenko, A., Kodela, R., & Kashfi, K. (2015) · Molecules · doi:10.3390/molecules200712481 · Cited by 14
Dual Role of Nitric Oxide in Cancer Biology
Pervin, S., Singh, R., Sen, S., & Chaudhuri, G. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1432-3_3 · Cited by 13
Fu, J., Zou, Y. S., Huang, Z., Chang, Y. Z., Zhou, Q., Zhang, H., Lai, Y., Peng, S., & Zhang, Y. (2015) · RSC Advances · doi:10.1039/c5ra00270b · Cited by 13
Self-citationNovel antileukemic agents derived from tamibarotene and nitric oxide donors
Bian, H., Feng, J., Li, M., & Xu, W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.103 · Cited by 13
Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety
Wang, C., Xia, G., Liu, X., Zhang, R., Chai, Y., Zhang, J., Li, X., Yang, Y., Wang, J., & Liu, M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.012 · Cited by 12
Carter, C. A., Oronsky, B. T., Caroen, S. Z., Scicinski, J. J., Cabrales, P., Degesys, A., & Brzezniak, C. E. (2016) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2016.04.007 · Cited by 12
Cited by
Nitric oxide signaling in health and disease
Lundberg, J. O., & Weitzberg, E. (2022) · Cell · doi:10.1016/j.cell.2022.06.010 · Cited by 826
Recent Advances in Design of Functional Biocompatible Hydrogels for Bone Tissue Engineering
Xue, X., Hu, Y., Deng, Y., & Su, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009432 · Cited by 532
Sung, Y.-C., Jin, P.-R., Chu, L.-A., Hsu, F.-F., Wang, M.-R., Chang, C.-C., Chiou, S.-J., Qiu, J. T., Gao, D.-Y., Lin, C.-C., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0570-3 · Cited by 452
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Self-citationSupramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Metadata
- Authors
- Huang, Z., Fu, J., & Zhang, Y.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-05-23
- Volume
- 60
- Issue
- 18
- Pages
- 7617-7635
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2615885638
- Cited by
- 406
- References
- 135
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.